Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) SHH

24.08

-0.88(-3.53%)

Updated at October 20 09:25AM

Currency In CNY

Valuation

Market Cap8.8B
Enterprise Value7.35B
P/E Ratio154.24
PEG Ratio-7.71
Price/Sales Ratio7.32
Price/Book Ratio3.08
Enterprise/Revenue6.7
Enterprise/EBITDA97.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.05
Operating Margin0.06

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue1.59B
Revenue/Share3.21
Gross Profit1.09B
EBITDA265.53M
Net Income100.35M
Diluted EPS0.22

Balance Sheet

Total Cash1.6B
Total Cash/Share3.43
Total Debt54.21M
Total Debt/Equity0.01
Current Ratio1.73
Book Value Per Share7.94

Price History

52-Week Change12.05
52-Week High30.32
52-Week Low18.45
Moving Average 50 Days25.67
Moving Average 200 Days23.42

Statistics

Average Volume12.27M
Shares Outstanding455.9M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor16983:10000
Last Split DateJanuary 24, 2007